Resveratrol Sensitizes Carfilzomib-Induced Apoptosis via Promoting Oxidative Stress in Multiple Myeloma Cells

The proteasome inhibitor is a target therapy for multiple myeloma (MM) patients, which has increased the overall survival rate of multiple myeloma in clinic. However, relapse and toxicity are major challenges for almost all MM patients. Thus, there is an urgent need for an effective and less toxic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qian, Yue, Yuanfang, Chen, Lin, Xu, Chang, Wang, Yan, Du, Liqing, Xue, Xiaolei, Liu, Qiang, Wang, Yafei, Fan, Feiyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961230/
https://www.ncbi.nlm.nih.gov/pubmed/29867453
http://dx.doi.org/10.3389/fphar.2018.00334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961230/
https://www.ncbi.nlm.nih.gov/pubmed/29867453
http://dx.doi.org/10.3389/fphar.2018.00334

Ejemplares similares